GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis

GBR 830 is a humanized mAb against OX40, a costimulatory receptor on activated T cells. OX40 inhibition might have a therapeutic role in T cell–mediated diseases, including atopic dermatitis (AD). This exploratory phase 2a study investigated the safety, efficacy, and tissue effects of GBR 830 in pat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of allergy and clinical immunology Jg. 144; H. 2; S. 482 - 493.e7
Hauptverfasser: Guttman-Yassky, Emma, Pavel, Ana B., Zhou, Lisa, Estrada, Yeriel D., Zhang, Ning, Xu, Hui, Peng, Xiangyu, Wen, Huei-Chi, Govas, Panayiota, Gudi, Girish, CA, Vinu, Fang, Hui, Salhi, Yacine, Back, Jonathan, Reddy, Venkateshwar, Bissonnette, Robert, Maari, Catherine, Grossman, Fred, Wolff, Gerhard
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States Elsevier Inc 01.08.2019
Elsevier Limited
Schlagworte:
ISSN:0091-6749, 1097-6825, 1097-6825
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!